About
Dr. Masoud Farshbaf received his bachelor's degree in Biomedical Engineering (Bioelectric) from Sahand University of Technology, Tabriz, Iran, in 2014. He earned his master's degree in Medical Nanotechnology from Tabriz University of Medical Sciences in 2017, where his research focused on the design and synthesis of pH- and thermo-sensitive magnetic nanocomposites for targeted drug delivery and MRI applications in lung cancer.
In 2017, Dr. Farshbaf began his Ph.D. in Medical Nanotechnology at Tabriz University of Medical Sciences under the supervision of Prof. Hadi Valizadeh and Dr. Paul R. Walker (University of Geneva). His doctoral research centered on the development, characterization, and functional analysis of drug-loaded dual peptide-decorated lipid nanoparticles designed to cross both the blood-brain barrier and blood-brain tumor barrier for targeted drug delivery to brain cancer cells.
Upon completing his Ph.D. in 2022, Dr. Farshbaf joined City of Hope (Duarte, CA) as a postdoctoral fellow. There, he worked on anti-PSCA NIR fluorescent antibody fragments for real-time intraoperative visualization of prostate cancer and applied immunoPET/CT to investigate the pharmacokinetics of 89Zr-labeled antibody fragments.
In 2024, Dr. Farshbaf began his second postdoctoral appointment in the laboratory of Prof. Michael Van Dam at UCLA, focusing on developing methods for microscale radiometal labeling of peptides and proteins for imaging and therapeutic applications.